Notify me when Richard Jacinto II files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Voting Common Shares, no par value | 9.6% | $34.1M | 4.96M | Richard Jacinto II | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|